In a study published in the journal Nature, the research team reveals how cells utilize specialized RNA-binding proteins to dynamically control mRNA localization and stability during cellular stress conditions. They zeroed in on two particular RNA-binding proteins, ELAVL1 and ELAVL2, which are known for their roles in regulating gene expression post-transcriptionally.
The team discovered that upon exposure to cellular stressors such as heat shock or oxidative stress, ELAVL1 and ELAVL2 rapidly redistribute from their original cytoplasmic locations to membrane-less compartments in the cytoplasm. These compartments are known as stress granules, which form as protective hubs where mRNAs and RNA-binding proteins congregate during cellular stress.
"This localization of ELAVL1 and ELAVL2 to stress granules seems to be a general response triggered by various types of cellular stress," says Professor Kim. "Our findings suggest that cells strategically recruit RNA-binding proteins to these compartments as a way of managing and adapting to stress conditions."
What's remarkable is that ELAVL1 and ELAVL2 do more than just relocate to stress granules; they actively select specific mRNAs to bring along with them. Using sophisticated RNA-sequencing techniques, the researchers found that ELAVL1 and ELAVL2 selectively bind and sequester a specific subset of protein-forming mRNAs to stress granules.
These sequestered mRNAs are mostly associated with essential cellular functions, including cell growth, proliferation, and DNA repair. By safeguarding these mRNAs, the researchers propose that cells can rapidly resume protein synthesis and recover more efficiently once stress conditions subside.
"It's as if cells have a 'stress-survival toolkit' ready in the form of these ELAVL proteins," explains Dr. Yutao Zhao, a postdoctoral scholar in the Kim lab and first author of the study. "During stress, they can selectively package essential mRNAs into stress granules, ensuring their stability until the cell is ready to resume growth."
The precise molecular mechanisms by which ELAVL1 and ELAVL2 discriminate between different mRNAs remain an exciting area for future investigation. Understanding these mechanisms could lead to potential therapeutic strategies for modulating RNA-binding protein-mediated mRNA sequestration in various disease contexts, including neurodegenerative diseases and cancer.